News | October 16, 2024
Wockhardt files fast-acting Insulin Aspart injection with DCGI
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as "?-lactam ENHANCER".
The company to receive upfront and milestone payments, in addition to royalties
The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector
Subscribe To Our Newsletter & Stay Updated
